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Background: Rho GTPases function as molecular switches in many different signaling pathways and control a
wide range of cellular processes. Rho GDP-dissociation inhibitors (RhoGDIs) regulate Rho GTPase signaling and can
function as both negative and positive regulators. The role of RhoGDIs as negative regulators of Rho GTPase signaling
has been extensively investigated; however, little is known about how RhoGDIs act as positive regulators. Furthermore,
it is unclear how this opposing role of GDIs influences the Rho GTPase cycle. We constructed ordinary differential
equation models of the Rho GTPase cycle in which RhoGDIs inhibit the regulatory activities of guanine nucleotide
exchange factors (GEFs) and GTPase-activating proteins (GAPs) by interacting with them directly as well as by
sequestering the Rho GTPases. Using this model, we analyzed the role of RhoGDIs in Rho GTPase signaling.
Results: The model constructed in this study showed that the functions of GEFs and GAPs are integrated into
Rho GTPase signaling through the interactions of these regulators with GDIs, and that the negative role of GDIs is to
suppress the overall Rho activity by inhibiting GEFs. Furthermore, the positive role of GDIs is to sustain Rho activation
by inhibiting GAPs under certain conditions. The interconversion between transient and sustained Rho activation
occurs mainly through changes in the affinities of GDIs to GAPs and the concentrations of GAPs.
Conclusions: RhoGDIs positively regulate Rho GTPase signaling primarily by interacting with GAPs and may
participate in the switching between transient and sustained signals of the Rho GTPases. These findings enhance
our understanding of the physiological roles of RhoGDIs and Rho GTPase signaling.
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Rho family GTPases are members of the Ras GTPase
superfamily and act as molecular switches in numerous
signaling pathways that control a variety of cellular pro-
cesses, including actin cytoskeletal organization, micro-
tubule dynamics, vesicle trafficking, cell cycle progression,
and cell polarization [1]. Most Rho GTPases cycle between
active GTP-bound and inactive GDP-bound states. There
are three classes of regulators of Rho GTPases, namely,
guanine nucleotide exchange factors (GEFs), GTPase-
activating proteins (GAPs), and GDP-dissociation inhibi-
tors (GDIs).* Correspondence: takahide@kanazawa-med.ac.jp
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unless otherwise stated.GEFs activate GTPases by promoting the exchange of
GDP for GTP. GAPs inactivate GTPases by stimulating
their intrinsic GTP-hydrolyzing activity. GDIs are known
to regulate only members of the Rho and Rab families
and not other families of the Ras superfamily, although a
GDI-like protein for Ras GTPases has been reported [2].
Unlike GEFs and GAPs, GDIs play several roles in the
regulation of the Rho family GTPases [3-6]. First, GDIs
bind GDP-bound GTPases and inhibit the dissociation
of GDP from GTPases, thereby preventing the promo-
tion of GDP/GTP exchange by GEFs and maintaining
the GTPases in an inactive state [7]. Second, although
the binding affinity of GDIs to GTP-bound GTPases
remains controversial [8-15], it is possible that GDIs
bind GTP-bound GTPases and inhibit both intrinsic
and GAP-promoted GTP hydrolyzing activity [8,16,17],is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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GDIs mediate the cycling of GTPases between cytosolic
and target sites [7].
GDIs for the Rho family GTPases can therefore act to
inhibit both the activation and inactivation of GTPases
by interacting with GDP- and GTP-bound GTPases,
respectively. This dual function of GDIs is noteworthy,
and adds to our understanding of the regulatory mech-
anisms of the Rho GTPase cycle, because GDIs for Rab
family GTPases show a marked preference for the
GDP-bound form [18]. Furthermore, it has also been
suggested that Rho GTPases are regulated by a fine
balance between GEF and GAP activities, and that the
inactivation of GAP activity is a physiologically import-
ant regulatory mechanism for activating Rho GTPases
[19]. Nonetheless, little is known about the significance
of the inhibition of GAP-promoted GTP hydrolyzing
activity by GDIs in the regulation of Rho signaling.
How the opposing roles of GDIs influence the Rho
GTPase cycle is also unclear.
Several ordinary differential equation models and process
models of the Rho GTPase cycle have been constructed
and analyzed [20-24]. In these models, GDIs inhibit the
functions of GEFs and GAPs by sequestering GDP-
bound and GTP-bound GTPases, respectively. However,
the actual mechanisms involved in GDI inhibition of
GEF and GAP activity are not fully understood. A previous
report suggested that RhoGDIs can physically interact
directly with both GEFs [25] and GAPs [26]. Based on
these observations, we constructed a model of the Rho
GTPase cycle in which GDIs inhibit the activities of
GEFs and GAPs not only by sequestering GTPases, but
also by direct physical interaction.
Using this model, we showed that the functions of
GEFs and GAPs are integrated into Rho GTPase signal-
ing through the interactions of these regulators with
GDIs and that the negative role of GDIs is to suppress
the overall Rho activity by inhibiting GEFs. Additionally,
the positive role of GDIs is to sustain Rho activation by
inhibiting GAPs. These observations illustrate the more
detailed roles RhoGDIs and further enhance our under-
standing of the physiological functions of Rho GTPase
signaling.
Results
Interaction of GDI with GAP sustains Rho activation
A Rho GTPase switch can be regulated by three classes of
regulators: GEFs, GAPs, and GDIs. In the canonical model
of the Rho GTPase cycle (Figure 1A, left), GEFs promote
GDP/GTP exchange, thereby activating Rho GTPases.
In contrast, GAPs promote GTP hydrolysis, thereby
inactivating Rho GTPases. GDIs sequester GDP-bound
GTPases from GEFs and keep them inactive; however,
GDIs can also sequester GTP-bound GTPases fromGAPs and keep them active. In this model, the Rho
GTPase cycle functions as a simple ON/OFF switch and
Rho activation is transiently elevated upon stimulation
(Figure 1A, right).
The majority of Rho GTPases exist in biologically in-
active cytosolic complexes with GDIs, and the dissoci-
ation of GTPases from GDIs is hypothesized to be
a prerequisite for activation by GEFs. However, it has
been suggested that GDI and Rho GTPase can si-
multaneously bind GEF or GAP and form a ternary
complex (GEF/GDI/Rho GTPase or GAP/GDI/Rho
GTPase) [25-27]. According to these observations, we
constructed a model of the Rho GTPase cycle (Figure 1B,
left) in which GDIs inhibit the activities of GEFs and GAPs
by physically interacting with them as well as by seques-
tering Rho GTPases (see Methods). We designated this
model the ‘GDI-integrated model’ because the activa-
tion dynamics and ultimate output of GEFs and GAPs
are integrated by GDIs to regulate Rho activity. Rho ac-
tivation is sustained for a longer period of time in this
model (Figure 1B, right), compared with the canonical
model (Figure 1A, right).
To clarify which interaction of GDIs with GEFs or
GAPs participates in this sustained Rho activation, we
further modified our GDI-integrated model. When the
interaction of GDIs with GEFs was removed (Figure 1C,
left), similar Rho activation dynamics, with a two-fold
increase in the overall level, were obtained (Figure 1C,
right). In contrast, when the interaction of GDIs with
GAPs was removed (Figure 1D, left), Rho activation level
decreased and was not sustained (Figure 1D, right).
These results therefore suggest that GDIs sustain Rho
activation through interaction with GAPs.
Influence of free (non-GTPase-complexed) GDI levels on
Rho activation dynamics
To confirm the contribution of GDIs in sustaining Rho
activation, we simulated Rho activation dynamics in the
presence of various cellular concentrations of free GDIs,
i.e., GDIs not complexed with GTPases. Based on the
literature [28], we calculated the concentration of free
RhoGDIα to be 0.7 μM (Additional file 1: Table S1). We
used a range of concentrations of free GDIs close to this
value to simulate the Rho activation dynamics. The
canonical model predicted that an increase in free GDIs
would simply lead to an overall decrease in Rho activa-
tion (Figure 2A). However, in our GDI-integrated model,
while the increase of free GDIs also led to an overall
decrease in Rho activation, this did not negate the
sustained Rho activation (Figure 2B). Unexpectedly, the
presence of free GDIs sustained the Rho activation level
beyond 1,800 min after stimulation, in contrast to the
cessation observed at this time point in the absence of
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Figure 1 (See legend on next page.)
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Figure 1 Representation of the models of Rho GTPase cycle regulation (left) and simulations of their Rho activation dynamics (right).
The activation levels of GTPases were defined as the concentration of the GTP-Rho/Effector complex. A) The canonical model of the Rho GTPase
cycle in which GDIs inhibit the activities of GEFs and GAPs by sequestering GTPase. B) The GDI-integrated model of the Rho GTPase cycle in which
GDIs inhibit the activities of GEFs and GAPs not only by sequestering GTPase but also by interacting with GEFs and GAPs. C) GDI/GEF interaction was
removed from the GDI-integrated model. D) GDI/GAP interaction was removed from the GDI-integrated model. All parameters and reactions in the
models are shown in Additional file 1: Tables S1 and S2. Reaction numbers (re#) correspond to the reaction numbers in Additional file 1: Table S2.
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concentration of GEF and GAP on Rho activation
dynamics
Phosphorylation affects the affinity of GDIs for various
Rho GTPases [29-33] and affects the function of GEFs
[34,35] and GAPs [36-38]. Therefore, phosphorylation
may modify the regulation of Rho signaling by GDIs,
GEFs and GAPs. To examine how the affinity of GDIs
for GEFs (KmGEF/GDI) and GAPs (KmGAP/GDI) affects the
ability of GDIs to sustain Rho activation, we simulated
the Rho activation dynamics at 0.01, 0.1, and 1.0 μM of
KmGEF/GDI and KmGAP/GDI in our model. The decrease of
KmGEF/GDI resulted in overall decrease of Rho activation
at all the tested concentrations of KmGAP/GDI (Figure 3A).
The Rho activation was markedly sustained at 0.01 and
0.1 μM of KmGAP/GDI and decreasing KmGEF/GDI did not
negate the sustained Rho activation (Figure 3A). Con-
versely, as the KmGAP/GDI value became smaller, the Rho
activation was sustained to a greater degree at all KmGEF/
GDI (Figure 3B). These results indicate that the sustained
Rho activation can primarily be attributed to the inter-
action between GAPs and GDIs, and the higher affinity
of GDIs for GAPs promotes sustained Rho activation.
It was also suggested that the local concentration of
GEFs and GAPs defined the modes of Rho GTPase
signaling [22]. We examined how the concentration of
GEFs and GAPs affected the ability of GDIs to sustain
Rho activation. We simulated the Rho activation dynam-
ics at 0.1, 0.3, and 0.9 μM concentrations of GEFs and
GAPs in our model. The decrease of GEF concentration
resulted in overall decrease of Rho activation at all of the
tested GAP concentrations (Figure 3C). The sustained
Rho activation was apparent only at 0.1 μM of GAP and
the decrease of GEF concentration did not negate this
sustained Rho activation (Figure 3C). However, at all of
the tested GEF concentrations, as the GAP concen-
trations became smaller, Rho activation was sustained
to a higher degree, and increasing GAP concentration
negated this sustained Rho activation (Figure 3D).
These results indicate that the sustained Rho activation
is dependent on the concentration of GAPs, and a lower
GAP concentration sustains Rho activation. Finally, we
compared the Rho activation dynamics at 0.01, 0.1, and
1.0 μM KmGAP/GDI under various concentrations of free
GDI. A decrease in the KmGAP/GDI value enhanced the
prolongation of Rho activation regardless of free GDIconcentration (Figure 4A). Surprisingly, at 0.01 μM
KmGAP/GDI, Rho activation was sustained for a signifi-
cant period of time, longer than 12,000 min (8.3 days),
after stimulation in the presence of free GDI (Figure 4B).
However, the overall levels of Rho activation markedly
decreased in association with an increase in free GDI.
These results suggest that GDIs enable extremely long-
term retention of the activated state of the Rho GTPases.
Discussion
It is well established that the main function of RhoGDIs
is to maintain Rho GTPases in inactive soluble com-
plexes. In many canonical models of the Rho GTPase
cycle, GDIs extract GTPases from the membrane and
sequester them as inactive cytosolic complexes. RhoGDIs
are therefore predominantly thought to act as negative
regulators; however, they inhibit both activation [7] and
inactivation [8,16,17] of GTPases. Little is known about
how the opposing functions of GDIs influence the Rho
GTPase cycle.
In the present study, we constructed a model of the
Rho GTPase cycle, designated as the GDI-integrated
model, in which GDIs inhibit the activities of GEFs and
GAPs by interacting with them in addition to sequester-
ing the Rho GTPases. This model indicated that GDIs
sustain the activation of Rho GTPase by interacting with
GAPs. Furthermore, as expected from the positive regu-
latory role of GDIs, (in other words, the inhibition of
GAP activity by GDIs), an increase in the intracellular
concentration of free GDIs enhanced the prolongation
of Rho activation despite the overall decrease in the Rho
activation level.
It was previously reported that the molar amount of
RhoGDIα is roughly equal to the molar total of the
RhoA, Rac1, and Cdc42 GTPases in several types of
cultured cells [28]. RhoGDIβ is strongly expressed in
hematopoietic cell lineages [39,40] and in other cell types
[41-43], though it is not as ubiquitous as RhoGDIα. Speci-
ficities of RhoGDIs for Rho GTPases are largely unknown,
but both RhoGDIα and RhoGDIβ can associate with
RhoA, Cdc42, and Rac1 in some cell types [3]. Therefore,
in RhoGDIβ-expressing cells, the total amount of RhoG-
DIα and RhoGDIβ may exceed the total amount of these
Rho GTPases. In such cases, RhoGDIs may exist in
a non-GTPase-complexed form in the cell and may
































































































Figure 2 Free (non-GTPase-complexed) GDI concentration
affects the prolongation of Rho activation in the GDI-integrated
model. Rho activation dynamics were simulated at various
concentration of free GDI. A) 600 min after stimulation in the
canonical model. B) 600 min after stimulation in the GDI-integrated
model. C) 1,800 min after stimulation in the GDI-integrated model.
The activation levels of GTPases were expressed as the concentration
of GTP-Rho/Effector complex.
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reports have presented contradictory evidence as to the
nature of the correlation between cancer progression
and RhoGDIβ expression level [44]. We have also re-
ported that RhoGDIβ plays a positive [41,45,46] and
negative [47] role in cancer progression. Several explana-
tions for this contradictory behavior of RhoGDIβ have
been proposed [44]. Our present study suggests that
RhoGDI can act both as a positive and negative regu-
lator of GTPases, and which role RhoGDI plays may
depend on its expression level. This presents at least
a partial explanation for the inconsistent correlation of
RhoGDIβ with cancer progression.
It has been proposed that intracellular signals are
transmitted through the dynamic activities of signaling
molecules (defined as the temporal change in activity of
a molecule) [48]. For example, in the case of ERK (extra-
cellular signal-regulated kinases), transient and sustained
activation states have been shown to result in different
cellular responses [49]. It is well established that GEFs
and GAPs function as positive and negative regulators of
Rho GTPase cycles, respectively. We have shown that
the functions of GEFs and GAPs are modulated by their
interactions with GDIs, and that the interconversion
between transient and sustained Rho activation occurs
mainly through changes in the affinities of GDIs to
GAPs and the concentrations of GAPs. The properties
of GDIs and GAPs are regulated by posttranscriptional
modifications [29-33,36-38] and the affinity between
GDIs and GAPs may be altered by such modifications.
Therefore, RhoGDIs and GAPs might participate in the
switching between transient and sustained signals of the
Rho GTPases. Although this mode seems not to be
common in the regulation of Rho GTPases, certain sets
of GTPases, GEFs, and GAPs may use this mode of
regulation.
In the present study, we proposed a simplified model
for positive regulation of Rho GTPases by GDIs. How-
ever, the model does not take into account GTPase
cycling between membrane and cytosol. Cells contain
membranous and cytoplasmic compartments, and typ-
ically, Rho GTPases function within the membranous
compartments. It has been shown that the efficient
cycling between inactive and active states of GTPases
can occur entirely within protein complexes assembled
A B C D
Figure 3 Prolongation of Rho activation in the GDI-integrated model is dependent on KmGAP/GDI and the GAP concentration. Rho activation
dynamics were simulated at various KmGEF/GDI values (A), KmGAP/GDI values (B), GEF concentration (C), and GAP concentrations (D) in the GDI-integrated
model. The activation levels of GTPases were expressed as the concentration of GTP-Rho/Effector complex.
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membrane-cytoplasmic shuttling of GTPases, and likely
can alter the concentrations of GTPases and their RhoGDI-
associated regulators at target sites in cells. Therefore, it is
necessary to take into account the shuttling processes in
developing a truly comprehensive model. Membrane-
cytoplasmic shuttling has been considered in a simulation
of the distribution of activated Cdc42 during the early
phase of yeast bud formation [23]. Additionally, a modeling
framework describing Rac cycling between membrane and
cytosol has been reported [21]. Because our model for the
Rho GTPase switch can be regarded as a basal signaling
module, these studies that have taken into account the Rho
GTPase shuttling processes should be incorporated into
our model of the Rho GTPase switch for a more detailed
and biologically-relevant model.
Conclusions
We constructed models of the Rho GTPase cycle in
which RhoGDIs inhibit the activities of GEFs and GAPs
by physically interacting with them, as well as by seques-
tering the Rho GTPases. This model showed that thefunctions of GEFs and GAPs are integrated into Rho
GTPase signaling through the interactions of these regu-
lators with GDIs, and thus, the interconversion between
transient and sustained Rho activation occurs by changes
mainly in the affinities of GDIs to GAPs and the concentra-
tions of GAPs. These results provide new insights into the
physiological roles of Rho GTPase signaling.
Methods
Construction of models
The pathway diagrams of the Rho GTPase cycle and
their simulation programs were described using CellDe-
signer (Systems Biology Institute, Tokyo, Japan) [50],
and were simulated by SOSLib in CellDesigner. All
kinetic reactions in the pathway diagrams in Figure 1
were described by ordinary differential equations based
on mass-action kinetics (reactions 1, 2, 3, 6, 7, and 8) or
Michaelis–Menten kinetics (reactions 4 and 5) [51,52].
In the canonical model (Figure 1A), we used a typical
Michaelis–Menten kinetic model to describe the pro-
moting activities of GEFs (reaction 4 in Figure 1A and
C) and GAPs (reaction 5 in Figure 1A and D) towards
A B
Figure 4 GDI enables extremely long-term retention of the activation state of Rho GTPases. Simulation of Rho activation dynamics at
KmGAP/GDI = 0.01, 01, and 1.0 μM in the presence of various free GDI concentrations (0–2.4 μM) in the GDI-integrated model. A) 600 min after
stimulation. B) 12,000 min after stimulation. The activation levels of GTPases were expressed as the concentration of GTP-Rho/Effector complex.
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and GAPs only by sequestering Rho GTPases.
The majority of Rho GTPases exist in biologically in-
active cytosolic complexes with GDIs and the dissoci-
ation of GTPases from GDIs is hypothesized to be a
prerequisite for activation by GEFs. However, it has beensuggested that βPIX (GEF), Rac1, and RhoGDIα form a
ternary complex [27] and that Bcr (GAP), Rac, and
RhoGDIα also form a ternary complex [26]. Further-
more, several studies have shown that GDIs directly
interact with both GEFs [25] and GAPs [26]. These
observations suggest that GDIs and Rho GTPases can
Ota et al. BMC Systems Biology  (2015) 9:3 Page 8 of 9simultaneously bind GEFs or GAPs, and form ternary
complexes. According to these observations, we constructed
a model of the Rho GTPase cycle (Figure 1B, left) in
which GDIs inhibit the activities of GEFs and GAPs by
interacting with them as well as by sequestering Rho
GTPases. We used the non-competitive inhibition
model of Michaelis–Menten kinetics to describe the
reactions in which GDIs inhibit the actions of GEFs
(reaction 4 in Figure 1B and D) and GAPs (reaction 5 in
Figure 1B and C), because in the non-competitive inhib-
ition model the inhibitor and substrate can simultaneously
bind the enzyme. The processes of GTPase cycling be-
tween membrane and cytosol are very important for un-
derstanding Rho activation dynamics. However, in the
present study we focused on the interaction of GDIs and
GEFs/GAPs and address how GDIs regulate GTPase activ-
ity through these interactions. Therefore, to simplify the
model we did not consider the membrane localization of
Rho GTPases and their regulators in our models.
Parameters and equations in the models are listed in
Tables S1 and S2 (Additional file 1). The kinetic pa-
rameters and initial concentrations of molecules were
determined based on previous studies [24,28,53-56] or
arbitrary values. The activation levels of GTPases were
defined as the concentrations of the GTP-Rho/Effector
complex. Model files are provided as .xml files (Additional
files 2 and 3) in the supplementary materials and can
be viewed using CellDesigner [50].
Additional files
Additional file 1: Tables S1-2.pdf. Table S1. lists the initial
concentrations of molecules. Table S2. lists the kinetic reactions, ordinary
differential equations, and parameters used in the models.
Additional file 2: Canonical model.xml. The canonical model file is
provided as an .xml file and can be viewed using CellDesigner.
Additional file 3: GDI-integrated model.xml. The GDI-integrated
model file is provided as an .xml file and can be viewed using CellDesigner.
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